Abstract
Positive airway pressure therapy is the most effective and immediate treatment for obstructive sleep apnea (OSA) other than tracheotomy. Over the period of more than 30 years it has been available, there have been continued improvements in design leading to greater comfort and acceptance. Newer forms of therapy including bilevel pressure and automated devices may be advantageous in some circumstances. Finding the best CPAP pressure usually involves in laboratory titration to eliminate inspiratory flow limitation. A “split-night” diagnostic and therapeutic protocol may be successful in many but not all cases. Recent studies have examined the effects of treatment on sleepiness, cognitive impairment, and affect with generally positive results. There is also evidence that treatment with positive airway pressure helps to reduce hypertension, atherosclerosis, risk of recurrent atrial fibrillation, and risk of stroke. Optimal treatment includes careful attention to choice of interface and objective monitoring of compliance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sullivan C, Issa F, Berthon-Jones M, et al. Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet. 1981;1:862–5.
Center for Medicare and Medicaid Services. Pub 100–03, Medicare National Coverage Determinations. Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA) (Effective 13 March 2008).
Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C, Parthasarathy S, Quan SF, Rowley JA, Positive Airway Pressure Titration Task Force of the American Academy of Sleep Medicine. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med. 2008;4(2):157–71.
Montserrat JM, Ballester E, Olivi H, et al. Time-course of stepwise CPAP titration. Behavior of respiratory and neurologic variables. Am J Respir Crit Care Med. 1995;152:1854–9.
Somiah M, Taxin Z, Keating J, Mooney AM, Norman RG, Rapoport DM, Ayappa I. Sleep quality, short-term and long-term CPAP adherence. J Clin Sleep Med. 2012;8(5):489–500.
Lettieri CJ, Collen JF, Eliasson AH, Quast TM. Sedative use during continuous positive airway pressure titration improves subsequent compliance: a randomized, double-blind, placebo-controlled trial. Chest. 2009;136:1263–8.
McArdle N, Grove A, Devereux G, et al. Split-night versus full-night studies for sleep apnoea/hypopnea syndrome. Eur Resp J. 2000;15:670–5.
Sanders MH, Costantino JP, Strollo PJ, et al. The impact of split-night polysomnography for diagnosis and positive pressure therapy titration on treatment acceptance and adherence in sleep apnea/hypopnea. Sleep. 2000;23:17–24.
Gay PC, Herold DL, Olson EJ. A randomized, double-blind clinical trial comparing continuous positive airway pressure with a novel bilevel pressure system for treatment of obstructive sleep apnea syndrome. Sleep. 2003;26:864–9.
Blau A, Minx M, Decker B, et al. Respiration and sleep in OSA patients treated with CPAP vs. auto bilevel pressure relief-pap. Sleep. 2008;31:A191.
Schafer H, Ewig S, Hasper E, Luderitz B. Failure of CPAP therapy in obstructive sleep apnoea syndrome: predictive factors and treatment with bilevel-positive airway pressure. Respir Med. 1998;92:208–15.
Ballard RD, Gay PC, Strollo PJ. Interventions to improve compliance in sleep apnea patients previously non-compliant with continuous positive airway pressure. J Clin Sleep Med. 2007;3:706–12.
Schwartz SW, Rosas J, Iannacone MR, et al. Correlates of a prescription for bilevel positive airway pressure for treatment of obstructive sleep apnea among veterans. J Clin Sleep Med. 2013;9(4):327–35.
Morgenthaler TI, Aurora RN, Brown T, Standards of Practice Committee of the AASM, et al. Practice parameters for the use of autotitrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome: an update for 2007. Sleep. 2008;31(1):141–7.
McArdle N, Singh B, Murphy M, et al. Continuous positive airway pressure titration for sleep apnoea: automatic versus manual titration. Thorax. 2010;65:606–11.
Kushida CA, Berry RB, Blau A, Crabtree T, Fietze I, Kryger MH, Kuna ST, Pegram GV, Penzel T. Positive airway pressure initiation: a randomized controlled trial to assess the impact of therapy mode and titration process on efficacy, adherence, and outcomes. Sleep. 2010;34(8):1083–92.
Massie CA, McArdle N, Hart RW, et al. Comparison between automatic and fixed positive airway pressure therapy in the home. Am J Respir Crit Care Med. 2003;167:20–3.
Masa JF, Jimenez A, Duran J, et al. Alternative methods of titrating continuous positive airway pressure. Am J Respir Crit Care Med. 2004;170:1218–24.
Chai CL, Pathinathan A, Smith BJ. Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea. Cochrane Database of Syst Rev. 2006; Issue 4. Art. No.: CD005308. Doi: 10.1002/14651858.CD005308.pub2.
Bakker J, Campbell A, Neill A. Randomized controlled trial comparing flexible and continuous positive airway pressure delivery: effects on compliance, objective and subjective sleepiness and vigilance. Sleep. 2010;33(4):523–9.
Wenzel M, Kerl J, Dellweg d. Expiratory pressure reduction (C-Flex method) versus fix CPAP in the therapy for obstructive sleep apnoea. Pneumologie. 2007;61:692–5.
George CF. Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP. Thorax. 2001;56:508–12.
Turkington PM, Sircar M, Saralaya D, Elliott MW. Time course of changes in driving simulator performance with and without treatment in patients with sleep apnoea hypopnea syndrome. Thorax. 2004;59:56–9.
Weaver TE, Maislin G, Dinges DF, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep. 2007;30(6):711–9.
Veasey S, Davis C, Fenik P, et al. Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions. Sleep. 2004;27:194–201.
Canessa N, Castronovo V, Cappa SF, et al. Obstructive sleep apnea: brain structural changes and neurocognitive function before and after treatment. Am J Respir Crit Care Med. 2011;183:1419–26.
Antic NA, Catcheside P, Buchan C, Hensley M, Naughton MT, Rowland S, Williamson B, Windler S, McEvoy RD. The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA. Sleep. 2011;34(1):111–9.
Kushida CA, Nichols DA, Holmes TH, et al. Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: the Apnea Positive Pressure Long-term Efficacy Study (APPLES). Sleep. 2012;35(12):1593–602.
Black J, Hirshkowitz M. Modafinil for the treatment of residual excessive sleepiness in nasal CPAP treated obstructive sleep apnea/hypopnea syndrome. Sleep. 2005;28:464–71.
Mendelson W. Depression in sleep apnea patients. Sleep Res. 1992;21:230.
Mosko S, Zetin M, Glen S, et al. Self-reported depressive symptomatology, mood ratings and treatment outcome in sleep disorders. J Clin Psychol. 1989;45:51–60.
Giles TL, Lasserson TJ, Smith BJ, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2006; Issue 1. Art. No.: CD001106.
Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease. Am J Resp Crit Care Med. 2001;163:19–25.
Alajmi M, Mulgrew AT, Fox J, et al. Impact of CPAP therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized clinical trials. Lung. 2007;185(2):67–72.
Pedrosa RP, Drager LF, Gonzaga CC, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58(5):811–7.
Martinez-Garcia M-A, Capote F, Campos-Rodriguez F, et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension, the HIPARCO trial. JAMA. 2013;310(22):2407–15.
Pedrosa RP, Drager LF, dePaula LKG, et al. Effects of OSA treatment on BP in patients with resistant hypertension, a randomized trial. Chest. 2013;144(5):1487–94.
Drager LF, Bortolotto LA, Figueiredo AC, et al. Effects of CPAP on early signs of atherosclerosis in OSA. Am J Resp Crit Care Med. 2007;176:706–12.
Sharma SK, Agarwal S, Damodaran D, et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med. 2011;365(24):2277–86.
Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with or without treatment with CPAP: an observational study. Lancet. 2005;365(9464):1046–53.
Ryan CM, Bayley M, Green R, et al. Influence of CPAP on outcomes of rehabilitation in stroke patients with OSA. Stroke. 2011;42(4):1062–7.
Abe H, Takahashi M, Yaegashi H, et al. Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients. Heart Vessels. 2010;25:63–9.
Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107:2589–94.
Fein AS, Shvilkin A, Shah D, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013;62(4):300–5.
McArdle N, Devereux G, Hedarnejad H, et al. Long term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respo Crit Care Med. 1999;159:1108–14.
Weaver T, Kribbs N, Pack A, et al. Night to night variability in CPAP use over the first three months of treatment. Sleep. 1997;20:278–83.
Lewis K, Seale L, Bartle I, et al. Early predictors of CPAP use for the treatment of obstructive sleep apnea. Sleep. 2004;27:134–8.
Schwab RJ, Badr SM, Epstein LJ, et al. An official American Thoracic Society statement: CPAP adherence tracking systems. Am J Resp Crit Care Med. 2013;188(5):613–20.
Kribbs NB, Pack AJ, Kline LR, et al. Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea. Am Rev Resp Dis. 1993;147:1162–8.
Yang Q, Phillips CL, Melehan KL, et al. Effects of short-term CPAP withdrawal on neurobehavioral performance in patients with obstructive sleep apnea. Sleep. 2006;29:545–52.
Young LR, Taxin ZH, Norman RG, Walsleben JA, Rapoport DM, Ayappa I. Response to CPAP withdrawal in patients with mild versus severe obstructive sleep apnea/hypopnea syndrome. Sleep. 2013;36(3):405–12.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Feinsilver, S.H. (2014). Positive Pressure Therapy for OSA. In: Pagel, J., Pandi-Perumal, S. (eds) Primary Care Sleep Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1185-1_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1185-1_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1184-4
Online ISBN: 978-1-4939-1185-1
eBook Packages: MedicineMedicine (R0)